Prevalence and Determinants of Oral Human Papillomavirus Infection in 500 Young Adults from Italy

被引:29
|
作者
Lupato, Valentina [1 ,2 ]
Holzinger, Dana [3 ]
Hofler, Daniela [3 ]
Menegaldo, Anna [1 ]
Rossi, Paolo Giorgi [4 ,5 ]
Del Mistro, Annarosa [6 ]
Da Mosto, Maria Cristina [1 ]
Pawlita, Michael [3 ]
Boscolo-Rizzo, Paolo [1 ]
机构
[1] Univ Padua, Dept Neurosci, Reg Ctr Head & Neck Canc, Treviso, Italy
[2] Azienda Osped S Maria degli Angeli, Unit Otolaryngol, Pordenone, Italy
[3] German Canc Res Ctr, Div Mol Diagnost Oncogen Infect, Infect Inflammat & Canc Program, Heidelberg, Germany
[4] Local Hlth Author, Interinst Epidemiol Unit, Reggio Emilia, Italy
[5] IRCCS, Arcispedale S Maria Nuova, Reggio Emilia, Italy
[6] Ist Oncol Veneto IRCCS, Immunol & Mol Oncol Unit, Padua, Italy
来源
PLOS ONE | 2017年 / 12卷 / 01期
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; SQUAMOUS-CELL CARCINOMA; RISK-FACTORS; OROPHARYNGEAL CANCER; HEALTHY-INDIVIDUALS; SEXUAL-BEHAVIORS; NATURAL-HISTORY; HPV PREVALENCE; UNITED-STATES; POPULATION;
D O I
10.1371/journal.pone.0170091
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although the prevalence of human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC) is increasing in developed countries and becoming a relevant health issue, the natural history of oral HPV infection is still unclear. Estimating the infection's prevalence in specific populations and identifying risk factors can widen our understanding of its natural history and help to delineate appropriate prevention strategies. This study sought to (i) determine oral HPV prevalence and genotype distribution in a large series of young Italian adults, (ii) validate an oral rinse sampling/storage protocol, and (iii) pinpoint factors associated with oral HPV infection. Five hundred students, nurses, and technicians (19-35 years-old) studying and working at/for the University of Padua were recruited. Each participant was provided with an oral rinse sampling kit and instructions for use. They were also asked to complete an anonymous questionnaire concerning their demographic characteristics and behaviors. The questionnaires and oral rinse containers were labeled with the same identification code number. The oral rinse samples were tested using a bead-based multiplex BSGP5+/6+-MPG genotyping assay which amplifies the L1 region of 51 mucosal HPV types. The prevalence of oral HPV infection was 4.0% (95% confidence interval (CI), 2.5%-6.1%); those of 14 high-risk HPV types and of HPV-type 16 (HPV16) infection were 2.2% (95% CI, 1.1%-3.9%) and 1.6% (95% CI, 0.6%-3.1%), respectively. HPV16 was the most frequent genotype (40.0% of oral HPV infections). No association was found between oral infection and the co-variables studied (gender, tobacco, alcohol and illegal drug use, number of sex and oral sex partners, HPV vaccination status, history of HPV and sexually transmitted infections, abnormal pap smears, recurrent tonsillitis and tonsillectomy). The oral rinse sampling protocol outlined here proved to be simple, efficient and well tolerated, and the prevalence rate can be considered reliable and thus useful to guide future research. Determinants of oral HPV infection are still unclear and further studies are certainly warranted.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Rates and Determinants of Oral Human Papillomavirus Infection in Young Men
    Edelstein, Zoe R.
    Schwartz, Stephen M.
    Hawes, Stephen
    Hughes, James P.
    Feng, Qinghua
    Stern, Michael E.
    O'Reilly, Sandra
    Lee, Shu-Kuang
    Xi, Long Fu
    Koutsky, Laura A.
    SEXUALLY TRANSMITTED DISEASES, 2012, 39 (11) : 860 - 867
  • [2] Prevalence and risk factors of oral human papillomavirus infection among 4212 healthy adults in Hebei, China
    Yu, Shuting
    Zhu, Yingying
    He, Huijing
    Hu, Yaoda
    Zhu, Xiaoli
    Diao, Wenwen
    Li, Shuguang
    Shan, Guangliang
    Chen, Xingming
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [3] Oral Human Papillomavirus Infection: Differences in Prevalence Between Sexes and Concordance With Genital Human Papillomavirus Infection, NHANES 2011 to 2014
    Sonawane, Kalyani
    Suk, Ryan
    Chiao, Elizabeth Y.
    Chhatwal, Jagpreet
    Qiu, Peihua
    Wilkin, Timothy
    Nyitray, Alan G.
    Sikora, Andrew G.
    Deshmukh, Ashish A.
    ANNALS OF INTERNAL MEDICINE, 2017, 167 (10) : 714 - +
  • [4] Prevalence and determinants of oral infection by Human Papillomavirus in HIV-infected and uninfected men who have sex with men
    Rollo, Francesca
    Latini, Alessandra
    Pichi, Barbara
    Colafigli, Manuela
    Benevolo, Maria
    Sinopoli, Ilenia
    Sperduti, Isabella
    Laquintana, Valentina
    Fabbri, Giulia
    Frasca, Mirko
    Cristaudo, Antonio
    Giuliani, Massimo
    Dona, Maria Gabriella
    PLOS ONE, 2017, 12 (09):
  • [5] Oral Human Papillomavirus Infection Hazard of Intimacy
    Schlecht, Hans P.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (07): : 724 - 725
  • [6] The Prevalence and Incidence of Oral Human Papillomavirus Infection Among Young Men and Women, Aged 18-30 Years
    Pickard, Robert K. L.
    Xiao, Weihong
    Broutian, Tatevik R.
    He, Xin
    Gillison, Maura L.
    SEXUALLY TRANSMITTED DISEASES, 2012, 39 (07) : 559 - 566
  • [7] Low Oral Human Papillomavirus Prevalence in Perinatally Human Immunodeficiency Virus-Infected Adolescents
    Winer, Rachel L.
    SEXUALLY TRANSMITTED DISEASES, 2016, 43 (08) : 501 - 502
  • [8] Epidemiology of oral human papillomavirus infection
    Chung, Christine H.
    Bagheri, Ashley
    D'Souza, Gypsyamber
    ORAL ONCOLOGY, 2014, 50 (05) : 364 - 369
  • [9] Prevalence of human papillomavirus university young women
    Montalvo, Maria T.
    Lobato, Ismelda
    Villanueva, Hilda
    Borquez, Celia
    Navarrete, Daniela
    Abarca, Juan
    Calaf, Gloria M.
    ONCOLOGY LETTERS, 2011, 2 (04) : 701 - 706
  • [10] Prevalence of Oral Human Papillomavirus Infection by Number of Vaccine Doses Among US Adults
    Abel, Mary Kathryn
    Mann, Amandeep K.
    Sonawane, Kalyani
    Kapp, Daniel S.
    Deshmukh, Ashish A.
    Chan, John K.
    JNCI CANCER SPECTRUM, 2021, 5 (06)